Park Medi World Ltd. received approval from the Securities and Exchange Board of India (SEBI) on August 14, 2025, to launch its Initial Public Offer (IPO). The company plans to move forward with the IPO process based on market conditions and other necessary approvals. The SEBI approval remains valid for 12 months from the date of issue.
The Park Medi World IPO is a Book Build Issue valued at ₹1,260.00 crore. It comprises a fresh issue of equity shares worth ₹960.00 crore and an offer for sale (OFS) of ₹300.00 crore. Once launched, the company’s equity shares will be proposed for listing on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
Nuvama Wealth Management Ltd. will act as the book-running lead manager for the issue, while Kfin Technologies Ltd. will serve as the registrar. Specific details such as IPO opening and closing dates, price bands, and lot sizes are yet to be announced. Interested investors can refer to the Park Medi World IPO Draft Red Herring Prospectus (DRHP) for more information.
Park Medi World IPO Objectives
The company plans to allocate the net proceeds from the issuance to the following purposes:
- A portion of the net proceeds will be used to repay or prepay certain outstanding borrowings of the company and its subsidiaries.
- Funds will support capital expenditure for developing a new hospital and expanding existing facilities under subsidiaries Park Medicity (NCR) and Blue Heavens.
- Proceeds will be utilised to acquire advanced medical equipment for the company and its subsidiaries, Blue Heavens and Ratangiri.
- A part of the funds will be reserved for potential acquisitions and other general corporate needs.
About Park Medi World Limited
Park Medi World Limited is the second-largest private hospital chain in North India, with a total bed capacity of 3,000 beds, and the largest in Haryana, where it operates 1,600 beds as of September 30, 2024. The company manages a network of 13 NABH-accredited multi-super-specialty hospitals under the ‘Park’ brand, with seven of them also NABL-accredited.
Its hospitals are spread across Haryana, New Delhi, Punjab, and Rajasthan, offering over 30 super-specialty and specialty services such as internal medicine, neurology, urology, gastroenterology, orthopaedics, and oncology. The company has a strong team of 891 doctors and 1,912 nurses delivering quality healthcare services.
Founded by Dr Ajit Gupta, the Park brand has expanded rapidly since the establishment of its first hospital in New Delhi in 2005. Through a series of acquisitions, Park Medi World has strengthened its presence in North India, with acquired hospitals contributing significantly to revenue and profitability.
The company follows a cluster-based growth approach, allowing operational efficiency and cost optimisation. Expansion plans are underway to increase total bed capacity to 4,350 by March 2028, with new hospitals being developed in Ambala, Panchkula, Rohtak, and Gorakhpur.
Each facility is equipped with ICUs, operating theatres, oxygen generation plants, and advanced cancer units. The company has also introduced robotic-assisted surgery systems at select hospitals to enhance patient recovery and outcomes, reinforcing its mission of delivering high-quality and affordable healthcare to a wider community.
Industry Outlook
- India’s healthcare expenditure stood at only 3.3% of GDP in 2022, significantly lower than countries like Brazil and Vietnam. With rising incomes, urbanisation, and an ageing population, healthcare spending is expected to grow steadily, creating large-scale opportunities for hospital chains to expand services and infrastructure.
- India has only 15 hospital beds per 10,000 people, much below the global median of 29 beds. This shortfall highlights strong demand for new hospitals and advanced healthcare facilities, especially in Tier-II and Tier-III cities.
- The growing prevalence of chronic diseases and the adoption of modern medical technologies are driving the need for multi-specialty and tertiary care hospitals, fostering rapid industry expansion.
How To Apply for the Park Medi World IPO Online?
- Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
- Locate the IPO Section: Navigate to the 'IPO' section on the platform.
- Select IPO: Find and select the Park Medi World IPO from the list of open IPOs.
- Enter the Lot Size: Specify the number of lots you want to bid for.
- Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
- Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
How To Check the Allotment Status of Park Medi World IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
- Angel One will notify you of your IPO allotment status via push notification and email.
Contact Details of Park Medi World Limited
Registered office: 12, Meera Enclave Near Keshopur, Bus Depot, Outer Ring Road, New Delhi 110 018, Delhi
Phone: : + 911246960000
E-mail:company.secretary@parkhospital.in
Park Medi World IPO Reservation
| Investor Category | Shares Offered |
| QIB Shares | Not more than 50% of the Offer |
| Retail Shares | Not less than 35% of the Offer |
| NII Shares | Not less than 15% of the Offer. |
Park Medi World IPO Promoter Holding
The promoters of the company are Dr. Ajit Gupta and Dr. Ankit Gupta.
| Share Holding Pre-Issue | 99.16% |
| Share Holding Post Issue | - |
Park Medi World Key Performance Indicators (KPIs)
| KPI | Values |
| ROE (%) | 18.25 |
| ROCE (%) | 16.07 |
| Debt/Equity (x) | 0.73 |
| RoNW (%) | 18.81 |
| PAT Margin (%) | 12.35 |
Park Medi World IPO Prospectus
Park Medi World IPO Registrar and Lead Managers
Park Medi World IPO Lead Managers
- Nuvama Wealth Management Limited
Registrar for Park Medi World IPO
Kfin Technologies Limited
- Contact Number: 04067162222, 04079611000
- Email Address: parkmedi.ipo@kfintech.com
- Park Medi World IPO Registrar: https://ipostatus.kfintech.com/
Financial Performance of Park Medi World Limited
| Particulars | Year ending on March 31, 2024 | Year ending on March 31, 2023 | Year ending on March 31, 2022 |
| Revenue From Operations (in ₹ million) | 12,310.66 | 12,545.95 | 10,843.83 |
| Profit/loss After Tax (in ₹ million) | 1,520.07 | 2,281.86 | 1,993.80 |
| Total Expenses (in ₹ million) | 10,416.57 | 9,553.72 | 8,155.85 |
| Cash and cash equivalents (in ₹ million) | 2,773.26 | 1,165.46 | 1,506.99 |
| Return on Equity (ROE) (%) | 18.25 | 35.82 | 42.44 |
| Return on Capital Employed (ROCE) (%) | 16.07 | 26.78 | 28.89 |
| EBITDA (in ₹ million) | 3,103.01 | 3,903.41 | 3,437.08 |
Park Medi World IPO Peer Comparison
| Name of Company | Face Value (₹ per Share) | P/E | Total Income (Fiscal 2024) (₹ million) | EPS (₹) |
| Park Medi World Ltd. | 2 | - | 12,630.84 | 3.95 |
| Apollo Hospitals Enterprise Ltd. | 5 | 99.46 | 1,91,655 | 62.50 |
| Fortis Healthcare Ltd. | 10 | 79.38 | 69,312 | 7.93 |
| Narayana Hrudayalaya Ltd. | 10 | 40.30 | 50,934 | 38.86 |
| Max Healthcare Institute Ltd. | 10 | 90.53 | 55,841 | 10.89 |
| Krishna Institute of Medical Sciences Ltd. | 2 | 66.14 | 25,112 | 7.75 |
| Global Health Ltd. | 2 | 68.90 | 33,498 | 17.80 |
| Jupiter Lifeline Hospitals Ltd. | 10 | 52.10 | 10,955 | 28.65 |
| Yatharth Hospital & Trauma Care Services Ltd. | 10 | 27.01 | 6,862 | 14.46 |
Strengths and Opportunities of Park Medi World Limited
- Second-largest private hospital chain in North India with 3,000 beds.
- Largest private hospital chain in Haryana operating 1,600 beds as of 2024.
- Network of 13 NABH-accredited multi-super-specialty hospitals with modern medical facilities.
- Successfully acquired seven hospitals, adding 1,650 beds to expand geographic reach.
- Strong profitability with restated PAT of ₹1,520.07 million in Fiscal 2024.
- Treats diverse patient base, primarily lower-middle and middle-class segments.
- Cluster-based expansion approach enhances operational efficiency and economies of scale.
- Focus on advanced medical technology and robotic surgeries to improve care quality.
Risks and Threats of Park Medi World Limited
- Highly dependent on 480 doctors and consultants for day-to-day hospital operations.
- Hospitals in Haryana contribute over 84.98% of revenue, posing regional concentration risk.
- Expansion projects in Ambala, Panchkula, Rohtak, Gorakhpur face potential delays and risks.
- Failure to attract or retain skilled doctors and nurses may reduce patient footfall.
- Consultancy doctors work part-time; replacing specialists could be time-consuming and costly.
- Key specialties contribute 92.17% of revenue; adverse changes could impact financial results.
- Reliance on in-patient department occupancy affects returns on capital expenditure and profits.
- High operating costs, including materials, employee benefits, and consultancy fees, may affect margins.
